products2come (p2c) is the first online partnering and technology transfer event for the life sciences. Search for innovations, business ideas, technologies, products and services and present your cooperation offers in live bilateral online meetings with representatives from leading life sciences companies and universities. Find out more on www.products2come.org
Live online partnering meetings
Find, contact and meet potential cooperation partners easily. Invite them to a 1-to-1 personal online meeting. Meet your partners in a telephone or skype conference or in a ssl-secured online meeting room. P2c will automatically schedule your meeting times based on your availability.
Experts from Abbott Diagnostics, AstraZeneca, Bayer Healthcare, B.Braun-Stiftung, Boehringer Ingelheim, Eli Lilly, Eppendorf, Novartis, Pfizer, Roche Diagnostics, Siemens, QIAGEN, Novo Nordisk and many other companies already joined p2c.
Live online presentations
Representatives from top life sciences companies have selected the most promising close-to-market technologies for live online presentations. Almost 300 technology offers and innovations from the pharmaceutical, biotechnology, diagnostics and medical technology community have been submitted so far. 60 of them will be presented live.
Submission of technology offers is still possible
NOTE: Universities and research institutions can still submit their technology and cooperation offers. If you would like to list more than 10 technology offers we recommend you to use our spreadsheet. Register and submit your life science technology offers via spreadsheet and return it to firstname.lastname@example.org. Deadline for spreadsheet submissions is 12 March 2015.
For less than 10 offers, just register and submit your offers directly on the partnering platform which will open on 2 February 2015.
Advantages of products2come
Learn more about the advantages of this innovative event at www.products2come.org.
Please don’t hesitate to contact us (+49 69-7564-124, email@example.com) in case of any questions.